Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Industry News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Industry News
Actelion Granted Chinese Approval for PAH Drug Uptravi (Selexipag... 12/12/2018
Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV 12/11/2018
Junshi Biosciences Aims to Raise $414M in Proposed Hong Kong IPO 12/11/2018
Lonza to Establish Strategic Biomanufacturing Base in China 12/11/2018
HitGen and Mitsubishi Tanabe Pharma Enter Discovery Research Part... 12/11/2018
UCB Announces Chinese Approval of Seizure Drug VIMPAT 12/11/2018
CBT Pharma and Strata Oncology Tie Up to Accelerate Development o... 12/10/2018
WuXi AppTec Expands Site in California for Pharmaceutical R&D... 12/10/2018
Gilead Launches HBV Drug Vemlidy in China 12/9/2018
Brii Bio Announced Partnerships to Jump-start Pipeline with Focus... 12/7/2018
Oral Insulin Moves Towards Becoming Reality in U.S., China 12/7/2018
IFPMA and RDPAC Introduce New Code for Pharmaceutical Marketing P... 12/7/2018
Changzhou Qianhong Biopharma Expands Facility for Polysaccharides... (free) 12/5/2018
PAREXEL and Eli Lilly to Develop Chinese Clinical Research Workfo... 12/5/2018
NMPA Approves Gilead's HIV Combo Drug Descovy 12/5/2018
Insurer Manulife-Sinochem Inks Deal with Healthcare Platform 111 ... 12/5/2018
China Approves New Indication of J&J's Prostate Cancer Drug ZYTIG... 12/5/2018
Revance Licenses China Rights of Neuromodulator RT002 to Fosun Ph... 12/4/2018
Roche’s Hemlibra (emicizumab) Approved for Import and Marketing ... 12/4/2018
Elpiscience Raises $35 Mln in A+ Round Led by Hillhouse Capital 12/4/2018
Sartorius and Immunochina Partner to Advance Immunotherapy Develo... (free) 12/4/2018
AstraZeneca to Promote R&D of Seven New Drugs in China 12/3/2018
CASI Pharma Announces Chinese Approval of EVOMELA 12/3/2018
Helsinn and Mundipharma China Announce Approval of ALOXI IV by th... 12/3/2018
Financial-related Company News in Brief 11/30/2018
Innovent and Chi-Med to Evaluate Combination of Sintilimab and Fr... 11/30/2018
MacroGenics and Zai Lab Announce License Agreement of Three I/O D... 11/30/2018
Online Healthcare Platform Jianke.com to Form Alliance with Pfize... 11/29/2018
WuXi Biologics and ABL Enter Development and Clinical Manufacturi... 11/29/2018
Immunitor to Initiate Clinical Development of Oral TB Vaccine in ... 11/29/2018
Page:4/17    Total number of articles:495  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links